% | $
Quotes you view appear here for quick access.

Dendreon Anonim Ortaklik Message Board

  • ernietag ernietag Mar 7, 2013 1:19 PM Flag

    Provenge commercial on TV know YYYYYYYYEEEEEEEEEESSSSSSSSSSS


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • you can see some nice screenshots on "ispot tv" -- just google this keywords: "provenge commercial spot tv"

      About This Commercial

      Description: When a man's prostate cancer returns his doctor tells him that this time it can be different. Provenge is a personalized treatment that counts on your own body to fight back and helps jump start the immune system to extend life.

      Advertiser: Provenge

      Last Aired: 1hr 48m ago on TNT


      Dendreon is readying a $5 million-per-quarter “targeted” DTC advertising campaign as the company seeks to goose growth in sales of its prostate cancer treatment Provenge.

      Said EVP, global commercial operations Joe DePinto in an earnings call this morning: “There are two main reasons that this campaign is important. The first is that when Provenge is recommended to patients by physicians, some patients may hesitate because they don't understand immunotherapy. Second, we know that when a well-educated consumer asks his doctor for Provenge and he is an appropriate patient, there's an extremely high connect rate.”

      In the company's first spot, a man says: “No matter what, people can count on me to get the job done, so when my prostate cancer returned, my doctor told me this time is going to be different—with Provenge, a personalized treatment that lets me count on my own body to fight back.” The tagline: “Provenge: helping you help yourself.”

      DePinto told analysts and investors that the company has also seen traction with its PROPEL direct-to-patient branded education program, though which physicians give presentations on the drug to patients at local and regional meetings of major prostate cancer support groups.

      “This enables us to access an extremely wide audience of potential patients,” he said, noting that the company conducted 75 PROPEL meetings in 2012, with an average of 20 patients per meeting, but some reaching more than 400 patients.

0.130.00(0.00%)Nov 18 4:00 PMEST